A recombinant vaccinia-rabies virus in the immunocompromised host: oral innocuity, progressive parenteral infection, and therapeutics (Q44927745)

7 December 2017

title

A recombinant vaccinia-rabies virus in the immunocompromised host: oral innocuity, progressive parenteral infection, and therapeutics (English)

1 reference

7 December 2017

0 references

rabies virus

1 reference

Koprowski H

1 reference

7 December 2017

Charles Edward Rupprecht

object named as

Rupprecht CE

1 reference

7 December 2017

Hanlon CA

1 reference

7 December 2017

Niezgoda M

1 reference

7 December 2017

Shankar V

1 reference

7 December 2017

Niu HS

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 February 1997

1 reference

7 December 2017

1 reference

inferred from page(s)

published in

Vaccine

1 reference

7 December 2017

1 reference

7 December 2017

1 reference

7 December 2017

page(s)

140-148

1 reference

Oral vaccination of foxes against rabies

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Control of rabies in wildlife

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Current oral rabies vaccination in Europe: an interim balance

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Oral vaccination of raccoons (Procyon lotor) with an attenuated (SAD-B19) rabies virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Expression of rabies virus glycoprotein from a recombinant vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Efficacy of a vaccinia-rabies glycoprotein recombinant virus vaccine in raccoons (Procyon lotor).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Oral vaccination of the fox against rabies using a live recombinant vaccinia virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Primate responses to a vaccinia-rabies glycoprotein recombinant virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Vaccinia virus: a suitable vehicle for recombinant vaccines?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Vaccinia virus expression vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

X-linked severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Risks and benefits of vaccinia vaccine use in the worldwide smallpox eradication campaign

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

The SCID mouse mutant: definition, characterization, and potential uses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Ineffectiveness and comparative pathogenicity of attenuated rabies virus vaccines for the striped skunk (Mephitis mephitis).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Amino acid sequence of the rabies virus glycoprotein deduced from its cloned gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Vaccine technologies: view to the future

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Primary multiplication site of the vaccinia-rabies glycoprotein recombinant virus administered to foxes by the oral route

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Oral rabies vaccine: evaluation of its infectivity in three species of rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Pathogenicity of SAD rabies vaccine given orally in chacma baboons (Papio ursinus)

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Chemotherapy of the acquired immune deficiency syndrome (AIDS): acyclic nucleoside phosphonate analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine in various models of herpes simplex virus infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Effects of vaccinia virus-expressed interleukin 2 on the immune system of sublethally irradiated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Immunodeficient mice recover from infection with vaccinia virus expressing interferon-gamma.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

NYVAC: a highly attenuated strain of vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Humoral and cell-mediated immune responses to recombinant vaccinia viruses in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Successful oral rabies vaccination of raccoons with raccoon poxvirus recombinants expressing rabies virus glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Oral immunization of wildlife against rabies: concept and first field experiments

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Oral immunization of foxes with avirulent rabies virus mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Swinepox Virus as a Vector for the Delivery of Immunogens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Nonreplicating viral vectors as potential vaccines: Recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Efficacy studies on a canarypox-rabies recombinant virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

Highly attenuated poxvirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900163-6

7 January 2021

10.1016/S0264-410X(96)00163-6

Identifiers

DOI

1 reference

7 December 2017

1 reference